Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

ACTAVIS INC
Mes dernières consult.
Most popular
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Watson Pharmaceuticals, Inc. : Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 10:05pm CET

PARSIPPANY, N.J., May 4, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch 2012 Healthcare Conference on Wednesday, May 16, 2012 at 10:00 AM Pacific Time at the Encore at the Wynn in Las Vegas, Nevada. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL: http://www.veracast.com/webcasts/baml/healthcare2012/id16635640.cfm

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology. Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the worlds established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

    CONTACTS:                         Investors:
                                      Lisa DeFrancesco
                                      (862) 261-7152

                                      Media:
                                      Charlie Mayr
                                      (862) 261-8030

(Photo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)

SOURCE Watson Pharmaceuticals, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ACTAVIS INC
11/17 ALLERGAN PLC : . (AGN) Shares Bought by Bank Hapoalim BM
11/16 ALLERGAN : to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conf..
11/16 ALLERGAN : Overactive Bladder Causes Significant Burden Regardless of Age Amongs..
11/16 ALLERGAN PLC : ex-dividend day
11/15 ALLERGAN : Receives FDA Approval for Use of VRAYLAR in the Maintenance Treatment..
11/14 ALLERGAN : Overactive Bladder Causes Significant Burden, Regardless of Age Among..
11/14 ALLERGAN : lands FDA approval for schizophrenia drug
11/13 ALLERGAN : to sell a quarter of its Teva stake in first quarter 2018
11/13 Pfizer creates chief operating officer role for Bourla
11/13 ALLERGAN : Receives FDA Approval For Use of VRAYLAR™ (cariprazine) in the ..
More news